SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

NowRx, Inc. – ‘1-U’ for 11/19/19

On:  Tuesday, 11/26/19, at 5:20pm ET   ·   For:  11/19/19   ·   Accession #:  1104659-19-67702

Previous ‘1-U’:  None   ·   Next & Latest:  ‘1-U’ on 10/12/21 for 10/1/21   ·   6 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/26/19  NowRx, Inc.                       1-U:9      11/19/19    3:247K                                   Toppan Merrill/FA

Current Report — Reg. A   —   Form 1-U
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 1-U         Current Report -- Reg. A                            HTML     11K 
 2: EX1U-2A CHARTER  Exhibit 2.1                                    HTML     67K 
 3: EX1U-3 HLDRS RTS  Exhibit 3.3                                   HTML     77K 


‘1-U’   —   Current Report — Reg. A


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 1-U

 

Current Report Pursuant to Regulation A

 

Date of Report: November 19, 2019

(Date of earliest event reported)

 

NowRx, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware47-4054162
(State or other incorporation)(I.R.S. Employer Identification No.)

 

2224 Old Middlefield Way 

Mountain View, CA 94043

(Full mailing address of principal executive offices)

 

(650) 386-5761

(Issuer’s telephone number, including area code)

 

Series A Preferred Stock

Series B Preferred Stock

(Title of each class of securities issued pursuant to Regulation A)

 

Item 9.Other Events.

 

Filing of Second Amended and Restated Certificate of Incorporation

 

On November 04, 2019, NowRx, Inc. (the “Company”) filed with the State of Delaware its Second Amended and Restated Certificate of Incorporation (the “Certificate”). The Certificate is filed as Exhibit 2.1 to this Current Report on Form 1-U.

 

Issuance of Additional SAFE Securities; Conversion of SAFE Securities

 

On September 26, 2019, the Company closed on the subscription for an additional simple agreement for future equity (“SAFE security”) for proceeds of $50,000, bringing its total proceeds from such agreements since June 30, 2019 to $675,000. The initial closing of the Regulation A offering for the Company’s Series B Preferred Stock offering will trigger the conversion provision of all of the SAFE securities. The Company held its first closing in connection with the Regulation A offering on November 19, 2019. All of the SAFE securities were converted into shares of the company’s Series B Preferred Stock at that date. Holders of the SAFE Securities signed a Series B Preferred Stock Conversion Agreement, which granted certain rights to those holders, including a right of first refusal. The form of Series B Preferred Stock Conversion Agreement is filed as Exhibit 3.3 to this Current Report on Form 1-U. 

 

 

 C: 

 

 

 

SIGNATURES

 

Pursuant to the requirements of Regulation A, the issuer has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  NowRx, Inc.
     
  By: /s/ Cary Breese
  Name:   Cary Breese
  Title:   Chief Executive Officer
     
  Date: November 26, 2019
     

 

 C: 

 

 

 

Exhibit Index

 

Exhibit No.   Description
     
2.1   Second Amended and Restated Certificate of Incorporation.
3.3   Form of Series B Preferred Stock Conversion Agreement

 

 C: 

 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘1-U’ Filing    Date    Other Filings
Filed on:11/26/19
For Period end:11/19/19
11/4/19
9/26/19
6/30/191-SA
 List all Filings 


6 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/28/22  NowRx, Inc.                       1-SA        6/30/22    3:946K                                   Toppan Merrill/FA
 5/02/22  NowRx, Inc.                       1-K        12/31/21    3:1.4M                                   Toppan Merrill/FA
 9/27/21  NowRx, Inc.                       1-A/A                  7:15M                                    Toppan Merrill/FA
 8/10/21  NowRx, Inc.                       1-A                    9:1.8M                                   Toppan Merrill/FA
 4/30/21  NowRx, Inc.                       1-K        12/31/20    2:788K                                   Toppan Merrill/FA
 9/25/20  NowRx, Inc.                       1-SA        6/30/20    2:696K                                   Toppan Merrill/FA
Top
Filing Submission 0001104659-19-067702   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Mar. 29, 6:08:11.1am ET